USE OF CALCIUM CARBONATE EMULSION FOR THE TREATMENT OF HYPERPHOSPHATEMIA ON CHRONIC HEMODIALYSIS PATIENTS REDUCES TOTAL ELEMENTAL CALCIUM DOSE

被引：0
|
作者：
Guinsburg, Martin [1 ,2 ]
Garrote, Norma [2 ]
Blanco, Marina [2 ]
Garcia, Leticia [1 ]
机构：
[1] Ctr Nefrol & Dialisis Moron, Nephrol, Moron, Argentina
[2] Ctr Nefrol & Dialisis Ciudad Evita, Nephrol, Ciudad Evita, Argentina
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
10.1093/ndt/gfv199.12
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP646
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE study)
    Qunibi, WY
    Hootkins, RE
    McDowell, LL
    Meyer, MS
    Simon, M
    Garza, RO
    Pelham, RW
    Cleveland, MVB
    Muenz, LR
    He, DY
    Nolan, CR
    KIDNEY INTERNATIONAL, 2004, 65 (05) : 1914 - 1926
  • [22] CONTROL OF PREDIALYTIC HYPERPHOSPHATEMIA BY ORAL CALCIUM ACETATE AND CALCIUM-CARBONATE - COMPARABLE EFFICACY FOR HALF THE DOSE OF ELEMENTAL CALCIUM GIVEN AS ACETATE WITHOUT LOWER INCIDENCE OF HYPERCALCEMIA
    MORINIERE, P
    DJERAD, M
    BOUDAILLIEZ, B
    ELESPER, N
    BOITTE, F
    WESTEEL, PF
    COMPAGNON, M
    BRAZIER, M
    ACHARD, JM
    FOURNIER, A
    NEPHRON, 1992, 60 (01): : 6 - 11
  • [23] A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients
    Bleyer, AJ
    Burke, SK
    Dillon, M
    Garrett, B
    Kant, KS
    Lynch, D
    Rahman, SN
    Schoenfeld, P
    Teitelbaum, I
    Zeig, S
    Slatopolsky, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (04) : 694 - 701
  • [24] THE TREATMENT OF UREMIC HYPERPHOSPHATEMIA WITH CALCIUM ACETATE AND CALCIUM-CARBONATE - A COMPARATIVE-STUDY
    SCHAEFER, K
    SCHEER, J
    ASMUS, G
    UMLAUF, E
    HAGEMANN, J
    VONHERRATH, D
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (03) : 170 - 175
  • [25] Efficacy and Safety of Calcium Acetate-Magnesium Carbonate in the Treatment of Hyperphosphatemia in Dialysis Patients
    Helal, Imed
    Elkateb, Hanene
    Hedri, Hafedh
    Hajri, Malika
    Ben Hamida, Fethi
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (06) : 1162 - 1167
  • [26] Treatment of hyperphosphatemia in hemodialysis patients: Results of the calcium acetate renagel evaluation (care study)
    Nolan, CR
    Quinibi, WY
    Hootkins, RE
    Pelham, RW
    Cleveland, MV
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : A28 - A28
  • [27] A comparative analysis of treatment of hyperphosphatemia with Sevelamer hydrochloride vs calcium acetate in hemodialysis patients
    Khalid, F
    Shafi, M
    Siddiqi, N
    Ali, Y
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A37 - A37
  • [28] Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial
    Ogata, Hiroaki
    Fukagawa, Masafumi
    Hirakata, Hideki
    Kagimura, Tatsuo
    Fukushima, Masanori
    Akizawa, Tadao
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (19): : 1946 - 1954
  • [29] Is lanthanum carbonate safer and more effective than calcium carbonate for hyperphosphatemia in dialysis patients?
    Masafumi Fukagawa
    Nature Clinical Practice Nephrology, 2005, 1 : 20 - 21
  • [30] Calcium Acetate/Magnesium Carbonate and Cardiovascular Risk Factors in Chronic Hemodialysis Patients
    Matias, Patricia Joao
    Jorge, Cristina
    Azevedo, Ana
    Laranjinha, Ivo
    Navarro, David
    Mendes, Marco
    Amaral, Tiago
    Ferreira, Carina
    Aires, Ines
    Gil, Celia
    Stuard, Stefano
    Ferreira, Anibal
    NEPHRON, 2016, 132 (04) : 317 - 326
12345